Notable Analyst Rating Changes 11/03: (TEVA) (ARO) (OPEN) Upgraded; (DNDN) (DXCM) (NLY) Downgraded

UPGRADES
Morgan Stanley lifts Teva Pharma (Nasdaq: TEVA) from Equal Weight to Overweight.

KeyBanc boosts Aeropostale, Inc. (NYSE: ARO) to Buy with a price target of $20. Click Here for more color.

Barclays upgrades OpenTable (Nasdaq: OPEN) from Underweight to Equalweight, maintains price target of $53.

Morgan Stanley raises Gol Linhas Aereas Inteligentes (NYSE: GOL) from Underweight to Overweight.

For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades

DOWNGRADES
Goldman Sachs downgrades Dendreon (Nasdaq: DNDN) from Buy to Neutral, its price target moves from $14 to $11. Click Here for more color.

CapitalOne lowers Transocean (NYSE: RIG) fro Add to Neutral.

DexCom (Nasdaq: DXCM) lowered by two Thursday:

• Morgan Keegan from Outperform to Market Perform; and
  
  
• SunTrust Robinson Humphrey from Neutral to Reduce.

Ladenburg Thalmann cuts Annaly Capital Management (NYSE: NLY) from Buy to Neutral.

For daily real-time Downgrades go to http://www.streetinsider.com/downgrades

NEW COVERAGE
Evercore Partners starts Apple (Nasdaq: AAPL) at Overweight and $600 price target.

Credit Suisse initiates St. Jude Medical (NYSE: STJ) with a Neutral, and $43 price target.

BofA/Merrill Lynch assumes Clorox (NYSE: CLX) with an Underperform, and $65 price target.

UBS begins Fortinet (Nasdaq: FTNT) at Neutral, and $24 price target.

For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage

Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Bank of America (BAC) Tops Q1 EPS by $0.07, Beats on Revenue
• South Africa Fund Manager Survey results - BofA
• Charles Schwab Corp. (SCHW) PT Raised to $70 at BofA Securities